BioSpace News Archive

Drug Development

Aria Deploys AI Differently to Drive New Insights

Aria Pharmaceuticals is using a unique computational approach to drug development that has increased its success rate by 30-fold when compared to traditional approaches.

January 15, 2022
·
5 min read
·
Gail Dutton
Biotech Beach

Dermavant Presents New Patient Satisfaction Data from PSOARING 3 Long Term Extension Trial of Tapinarof in Adults with Plaque Psoriasis at the 2022 Winter Clinical Dermatology Conference

Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, announced results from a patient satisfaction questionnaire in the long-term, open-label Phase 3 PSOARING 3 extension study of tapinarof cream 1% once daily for the treatment of plaque psoriasis in adults.

January 15, 2022
·
6 min read
Zymeworks Reports Inducement Grant Under New York Stock Exchange Listed Company Manual Rule

Zymeworks Inc. reported, as required by the New York Stock Exchange Listed Company Manual Rule 303A.08, an equity inducement award to Mr. Kenneth Galbraith, Zymeworks’ new Chair, President and Chief Executive Officer.

January 15, 2022
·
3 min read